pyrroles has been researched along with su 11652 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cherrington, JM; Chien, MB; Liao, AT; London, CA; McMahon, G; Mendel, DB; Shenoy, N | 1 |
| Heryanto, B; Lipson, KE; Rogers, PA | 1 |
| Chen, Y; Fu, X; Guo, Y; Xu, X; Zhao, ZJ | 1 |
| Ellegaard, AM; Groth-Pedersen, L; Jäättelä, M; Kirkegaard, T; Klumperman, J; Nylandsted, J; Oorschot, V | 1 |
| Ago, T; Arimura, K; Kamouchi, M; Kitazono, T; Kuroda, J; Makihara, N; Matsuo, R; Nakamura, K; Nishimura, A; Sugimori, H; Tachibana, M; Wakisaka, Y | 1 |
| Cordeiro, AT; de Giuseppe, PO; de Oliveira, AHC; Honorato, RV; Murakami, MT; Oliveira, PSL; Rocco, SA; Severiano, KU; Souza, TACB; Vieira, PS; Zanphorlin, LM | 1 |
6 other study(ies) available for pyrroles and su 11652
| Article | Year |
|---|---|
Inhibition of constitutively active forms of mutant kit by multitargeted indolinone tyrosine kinase inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Survival; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Indoles; Mast-Cell Sarcoma; Mutation; Phosphorylation; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit; Pyrroles; Tumor Cells, Cultured | 2002 |
Effect of angiogenesis inhibitors on oestrogen-mediated endometrial endothelial cell proliferation in the ovariectomized mouse.
Topics: Angiogenesis Inhibitors; Animals; Cell Division; Endometrium; Endothelial Growth Factors; Endothelium, Vascular; Estrogens; Female; Fibroblast Growth Factors; Immune Sera; Indoles; Intercellular Signaling Peptides and Proteins; Lymphokines; Mice; Mice, Inbred Strains; Ovariectomy; Platelet-Derived Growth Factor; Progesterone; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2003 |
SU11652 Inhibits tyrosine kinase activity of FLT3 and growth of MV-4-11 cells.
Topics: Cell Growth Processes; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; Humans; Indoles; Leukemia, Myeloid, Acute; Protein Kinase Inhibitors; Pyrroles; Signal Transduction | 2012 |
Sunitinib and SU11652 inhibit acid sphingomyelinase, destabilize lysosomes, and inhibit multidrug resistance.
Topics: Apoptosis; Cell Survival; Drug Resistance, Neoplasm; HeLa Cells; Humans; Indoles; Lysosomes; MCF-7 Cells; Neoplasms; Pyrroles; Sphingomyelin Phosphodiesterase; Sunitinib | 2013 |
Involvement of platelet-derived growth factor receptor β in fibrosis through extracellular matrix protein production after ischemic stroke.
Topics: Animals; Brain; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Extracellular Matrix Proteins; Fibrosis; Gene Expression Regulation; Indoles; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Pericytes; Pyrroles; Rats; Receptor, Platelet-Derived Growth Factor beta; RNA, Messenger; Time Factors | 2015 |
Pyrrole-indolinone SU11652 targets the nucleoside diphosphate kinase from Leishmania parasites.
Topics: Antiprotozoal Agents; Calorimetry; Cell Survival; Dose-Response Relationship, Drug; Indoles; Leishmania major; Molecular Docking Simulation; Mutagenesis, Site-Directed; Nucleoside-Diphosphate Kinase; Parasitic Sensitivity Tests; Protein Kinase Inhibitors; Pyrroles; Structure-Activity Relationship | 2017 |